These preliminary results are unaudited and are based on management’s initial analysis of operations for the fourth quarter and full year periods ended December 31, 2025, and are therefore subject to ...
SAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, ...
Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today ...
The diabetic neuropathy market is poised for growth driven by clinical evidence, patient-centric care, digital health models, and innovative pharmacologic options. Key opportunities include enhancing ...
Rising Chronic Pain Burden, Aging Populations, and Rapid Innovation Accelerate Demand for Advanced, Non-Opioid Pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback